Differential Selectivity of Cytochrome P450 Inhibitors Against Probe Substrates in Human and Rat Liver Microsomes

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1998 Mar 10

PMID 9491822

Citations 61

Authors

V A Eagling

J F Tjia

D J Back

Affiliations

Soon will be listed here.

Abstract

Aims: Chemical inhibitors of cytochrome P450 (CYP) are a useful tool in defining the role of individual CYPs involved in drug metabolism. The aim of the present study was to evaluate the selectivity and rank the order of potency of a range of isoform-selective CYP inhibitors and to compare directly the effects of these inhibitors in human and rat hepatic microsomes.

Methods: Four chemical inhibitors of human cytochrome P450 isoforms, furafylline (CYP1A2), sulphaphenazole (CYP2C9), diethyldithiocarbamate (CYP2E1), and ketoconazole (CYP3A4) were screened for their inhibitory specificity towards CYP-mediated reactions in both human and rat liver microsomal preparations. Phenacetin O-deethylation, tolbutamide 4-hydroxylation, chlorzoxazone 6-hydroxylation and testosterone 6beta-hydroxylation were monitored for enzyme activity.

Results: Furafylline was a potent, selective inhibitor of phenacetin O-deethylation (CYP1A2-mediated) in human liver microsomes (IC50 = 0.48 microM), but inhibited both phenacetin O-deethylation and tolbutamide 4-hydroxylation (CYP2C9-mediated) at equimolar concentrations in rat liver microsomes (IC50 = 20.8 and 24.0 microM respectively). Sulphaphenazole demonstrated selective inhibition of tolbutamide hydroxylation in human liver microsomes but failed to inhibit this reaction in rat liver microsomes. DDC demonstrated a low level of selectivity as an inhibitory probe for chlorzoxazone 6-hydroxylation (CYP2E1-mediated). DDC also inhibited testosterone 6beta-hydroxylation (CYP3A-mediated) in man and rat, and tolbutamide 4-hydroxylase activity in rat. Ketoconazole was a very potent, selective inhibitor of CYP3A4 activity in human liver (IC50 = 0.04 microM). Although inhibiting CYP3A in rat liver it also inhibited all other reactions at concentrations < or = 5 microM.

Conclusions: It is evident that CYP inhibitors do not exhibit the same selectivity in human and rat liver microsomes. This is due to differential selectivity of the inhibitors and/or differences in the CYP isoform responsible for metabolism in the different species.

Citing Articles

Effect of eugenol on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes.

Alharbi N, Ahad A, Bin Jardan Y, Al-Jenoobi F Saudi Pharm J. 2024; 32(7):102118.

PMID: 38841106 PMC: 11152732. DOI: 10.1016/j.jsps.2024.102118.

Development of a rapid HPLC-fluorescence method for monitoring warfarin metabolites formation: In vitro studies for evaluating the effect of piperine on warfarin metabolism and plasma coagulation.

Zayed A, Hadieh M, Al Hroot J, Hameedat F, Jaber S Heliyon. 2024; 10(10):e31266.

PMID: 38807873 PMC: 11130653. DOI: 10.1016/j.heliyon.2024.e31266.

A general fluorescence off/on strategy for fluorogenic probes: Steric repulsion-induced twisted intramolecular charge transfer (sr-TICT).

Hanaoka K, Ikeno T, Iwaki S, Deguchi S, Takayama K, Mizuguchi H Sci Adv. 2024; 10(7):eadi8847.

PMID: 38363840 PMC: 10871538. DOI: 10.1126/sciadv.adi8847.

Bielectrode Strategy for Determination of CYP2E1 Catalytic Activity: Electrodes with Bactosomes and Voltammetric Determination of 6-Hydroxychlorzoxazone.

Kuzikov A, Masamrekh R, Filippova T, Tumilovich A, Strushkevich N, Gilep A Biomedicines. 2024; 12(1).

PMID: 38255257 PMC: 10812958. DOI: 10.3390/biomedicines12010152.

A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment.

Lee J, Beers J, Geffert R, Jackson K Biomolecules. 2024; 14(1).

PMID: 38254699 PMC: 10813492. DOI: 10.3390/biom14010099.

References

Imaoka S, Terano Y, Funae Y . Constitutive testosterone 6 beta-hydroxylase in rat liver. J Biochem. 1988; 104(3):481-7. DOI: 10.1093/oxfordjournals.jbchem.a122494. View

MEREDITH C, Maldonado A, Speeg Jr K . The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro. Drug Metab Dispos. 1985; 13(2):156-62. View

Sesardic D, Edwards R, Davies D, Thomas P, Levin W, Boobis A . High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat. Biochem Pharmacol. 1990; 39(3):489-98. DOI: 10.1016/0006-2952(90)90055-p. View

Sesardic D, Boobis A, Murray B, Murray S, Segura J, de la Torre R . Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol. 1990; 29(6):651-63. PMC: 1380167. DOI: 10.1111/j.1365-2125.1990.tb03686.x. View

Veronese M, McManus M, Laupattarakasem P, Miners J, Birkett D . Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450. Drug Metab Dispos. 1990; 18(3):356-61. View

Boobis A, Sesardic D, Murray B, Edwards R, Singleton A, Rich K . Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica. 1990; 20(11):1139-61. DOI: 10.3109/00498259009046835. View

Peter R, Bocker R, Beaune P, Iwasaki M, Guengerich F, Yang C . Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol. 1990; 3(6):566-73. DOI: 10.1021/tx00018a012. View

Guengerich F, Kim D, Iwasaki M . Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991; 4(2):168-79. DOI: 10.1021/tx00020a008. View

Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J . Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J. 1992; 6(2):752-8. DOI: 10.1096/fasebj.6.2.1371482. View

10.

Soucek P, Gut I . Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica. 1992; 22(1):83-103. DOI: 10.3109/00498259209053106. View

11.

Veronese M, Doecke C, Mackenzie P, McManus M, Miners J, REES D . Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily. Biochem J. 1993; 289 ( Pt 2):533-8. PMC: 1132200. DOI: 10.1042/bj2890533. View

12.

Tassaneeyakul W, Birkett D, Veronese M, McManus M, Tukey R, Quattrochi L . Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J Pharmacol Exp Ther. 1993; 265(1):401-7. View

13.

Bickett D, Mackenzie P, Veronese M, Miners J . In vitro approaches can predict human drug metabolism. Trends Pharmacol Sci. 1993; 14(8):292-4. DOI: 10.1016/0165-6147(93)90043-j. View

14.

Kunze K, TRAGER W . Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem Res Toxicol. 1993; 6(5):649-56. DOI: 10.1021/tx00035a009. View

15.

Purba H, Maggs J, Orme M, Back D, Park B . The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol. 1987; 23(4):447-53. PMC: 1386094. DOI: 10.1111/j.1365-2125.1987.tb03074.x. View

16.

Sonderfan A, Arlotto M, Dutton D, McMillen S, Parkinson A . Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys. 1987; 255(1):27-41. DOI: 10.1016/0003-9861(87)90291-8. View

17.

Waxman D, Attisano C, Guengerich F, Lapenson D . Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys. 1988; 263(2):424-36. DOI: 10.1016/0003-9861(88)90655-8. View

18.

Back D, Tjia J, Karbwang J, COLBERT J . In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines. Br J Clin Pharmacol. 1988; 26(1):23-9. PMC: 1386495. DOI: 10.1111/j.1365-2125.1988.tb03359.x. View

19.

Wrighton S, Vandenbranden M, Stevens J, Shipley L, Ring B, Rettie A . In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metab Rev. 1993; 25(4):453-84. DOI: 10.3109/03602539308993982. View

20.

Carriere V, Goasduff T, Ratanasavanh D, Morel F, GAUTIER J, Guillouzo A . Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol. 1993; 6(6):852-7. DOI: 10.1021/tx00036a015. View